Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,606.49
(
-0.27%
)
US TECH 100
23,612.00
(
-0.46%
)
Dow Jones
46,021.43
(
-0.44%
)
Brent Oil
105.03
(
0.57%
)
Bitcoin
70,700.00
(
1.15%
)
News Focus
News Focus

Replies to post #35247 on Biotech Values

Replies to #35247 on Biotech Values
icon url

DewDiligence

10/10/06 5:28 PM

#35249 RE: jbog #35247

Lucentis – 80% of the $153M in sales were from patients who switched treatment from Macugen, Visudyne, or Avastin. (Source: DNA CC)